March 2022

March 24, 2022

Come Again? Communicating Clearly About Risk of Recurrence After Early-Stage Breast Cancer

Mary Lou Smith and colleagues at the Research Advocacy Network recently explored how well patients with early-stage breast cancer understand risk of their cancer coming back
March 24, 2022

Now Enrolling: The EAQ202 clinical trial seeks to provide young people with cancer a better way to report their experiences during cancer treatment

This pilot study will test some exciting new interactive features that ECOG-ACRIN would like to add to the surveys and questionnaires used to evaluate the experiences of young patients
March 24, 2022

Ongoing Trial: The BAMM2 trial (EA6191) explores adding the drug hydroxychloroquine to standard treatment for certain patients with melanoma that has progressed after immunotherapy

This study is evaluating the effect of adding hydroxychloroquine to the usual treatment for patients with advanced, BRAF-mutant melanoma
March 24, 2022

Trial Results: ECOG-ACRIN Research Round-Up – Spring 2022

Summaries of recently reported ECOG-ACRIN research results